Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 127.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 38,471
  • Market Cap: £133.06m
  • RiskGrade: 95

Cello Health revenues and headline profits grow in Q1

By Iain Gilbert

Date: Wednesday 08 May 2019

LONDON (ShareCast) - (Sharecast News) - Healthcare-focused advisory group Cello Health saw like-for-like net revenue and headline pre-tax profits grow in the first quarter of its trading year, something it expects to carry over into the second quarter.
Chairman Chris Jones told investors at the group's annual general meeting on Wednesday that Cello had seen "a very good start to the year" and was confident of its second-quarter outlook.

At a segment operating level, Jones revealed Cello had also had an "excellent first quarter". In particular, the AIM-listed firm's chair said performances in its consulting businesses and in the US overall were "notable".

"The board is therefore confident of achieving a successful full year result in 2019, in line with expectations," said Jones.

Cello also said the group's balance sheet remained strong, with better than expected cash conversion so far in 2019, continuing "the strong cash conversion performance" delivered in 2018. He also noted the group was continuing to assess "suitable acquisitive growth opportunities" in the US.

As of 1035 BST, Cello shares had picked up 1% to 133.32p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 127.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 139.50
52 Week Low 96.00
Volume 38,471
Shares Issued 104.77m
Market Cap £133.06m
RiskGrade 95

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.63% below the market average67.63% below the market average67.63% below the market average67.63% below the market average67.63% below the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Price Trend
9.70% above the market average9.70% above the market average9.70% above the market average9.70% above the market average9.70% above the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average
Income
10.57% above the market average10.57% above the market average10.57% above the market average10.57% above the market average10.57% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
32.64% below the market average32.64% below the market average32.64% below the market average32.64% below the market average32.64% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 23-Sep-2019

Time Volume / Share Price
16:15 6,922 @ 127.22p
14:50 3,930 @ 127.22p
14:41 1,878 @ 126.55p
14:24 6,283 @ 127.22p
12:09 4,290 @ 126.62p

Cello Health Key Personnel

CEO Mark Scott

Top of Page